Virtus Biotech Clinical TriaBBCETF
13F holders, Q1 2025 (March 31)9holders
3new positions
3sold out
$17.54avg. 13F price*
At the end of Q1 2025, 9 institutions reported holding Virtus Biotech Clinical Tria (BBC) in their 13F filings, unchanged from Q4 2024. 3 opened new positions and 3 sold out. The largest holders were Jane Street Group, LLC ($371K), LPL Financial LLC ($209K) and Toronto Dominion Bank ($175K).
- Company
- Virtus Biotech Clinical Tria
- Filed as
- ETFIS SER TR I (Q1 2025)
- CUSIP
- 26923G301
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $560K |
| Exits | 3 | $1.1M |
All 13F filers, Q4 2024 → Q1 2025: 31,951 shares bought and 48,528 shares sold, net −16,577 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Jane Street Group, LLC | 0.00% | New | 21,149 | $371K |
| LPL Financial LLC | 0.00% | Reduce -8.6% | 11,914 | $209K |
| Toronto Dominion Bank | 0.00% | New | 10,000 | $175K |
| Morgan Stanley | 0.00% | Reduce -26.6% | 8,444 | $148K |
| US Bancorp \de | 0.00% | No change | 1,000 | $18K |
| Dynamic Wealth Strategies, LLC | 0.01% | New | 802 | $14K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 294 | $5K |
| Allworth Financial LP | 0.00% | No change | 10 | $187 |
| NewEdge Advisors, LLC | 0.00% | No change | 5 | $88 |
"% of holder's portfolio" is BBC's weight in each manager's 13F, not the share of Virtus Biotech Clinical Tria the manager owns.